These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20564319)

  • 1. Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.
    Kim ST; Cheng Y; Hsu FC; Jin T; Kader AK; Zheng SL; Isaacs WB; Xu J; Sun J
    Prostate; 2010 Dec; 70(16):1729-38. PubMed ID: 20564319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.
    Tao S; Wang Z; Feng J; Hsu FC; Jin G; Kim ST; Zhang Z; Gronberg H; Zheng LS; Isaacs WB; Xu J; Sun J
    Carcinogenesis; 2012 Mar; 33(3):598-603. PubMed ID: 22219177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post genome-wide association studies functional characterization of prostate cancer risk loci.
    Jiang J; Cui W; Vongsangnak W; Hu G; Shen B
    BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S9. PubMed ID: 24564736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.
    Lu Y; Sun J; Kader AK; Kim ST; Kim JW; Liu W; Sun J; Lu D; Feng J; Zhu Y; Jin T; Zhang Z; Dimitrov L; Lowey J; Campbell K; Suh E; Duggan D; Carpten J; Trent JM; Gronberg H; Zheng SL; Isaacs WB; Xu J
    Prostate; 2012 Mar; 72(4):376-85. PubMed ID: 21671247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.
    Chen H; Yu H; Wang J; Zhang Z; Gao Z; Chen Z; Lu Y; Liu W; Jiang D; Zheng SL; Wei GH; Issacs WB; Feng J; Xu J
    Prostate; 2015 Sep; 75(12):1264-76. PubMed ID: 26015065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.
    Na R; Liu F; Zhang P; Ye D; Xu C; Shao Q; Qi J; Wang X; Chen Z; Wang M; He D; Wang Z; Zhou F; Yuan J; Gao X; Wei Q; Yang J; Jiao Y; Ou-Yang J; Zhu Y; Wu Q; Chen H; Lu D; Shi R; Lin X; Jiang H; Wang Z; Jiang D; Sun J; Zheng SL; Ding Q; Mo Z; Sun Y; Xu J
    Prostate; 2013 Nov; 73(15):1623-35. PubMed ID: 24038036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide two-locus epistasis scans in prostate cancer using two European populations.
    Tao S; Feng J; Webster T; Jin G; Hsu FC; Chen SH; Kim ST; Wang Z; Zhang Z; Zheng SL; Isaacs WB; Xu J; Sun J
    Hum Genet; 2012 Jul; 131(7):1225-34. PubMed ID: 22367438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide pleiotropy scan for prostate cancer risk.
    Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
    Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk.
    Jin G; Sun J; Isaacs SD; Wiley KE; Kim ST; Chu LW; Zhang Z; Zhao H; Zheng SL; Isaacs WB; Xu J
    Carcinogenesis; 2011 Nov; 32(11):1655-9. PubMed ID: 21856995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to prostate cancer in Taiwan: A genome-wide association study.
    Bau DT; Tsai CW; Chang WS; Yang JS; Liu TY; Lu HF; Wang YW; Tsai FJ
    Mol Carcinog; 2024 Apr; 63(4):617-628. PubMed ID: 38390760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men.
    Liu F; Hsing AW; Wang X; Shao Q; Qi J; Ye Y; Wang Z; Chen H; Gao X; Wang G; Chu LW; Ding Q; OuYang J; Gao X; Huang Y; Chen Y; Gao YT; Zhang ZF; Rao J; Shi R; Wu Q; Wang M; Zhang Z; Zhang Y; Jiang H; Zheng J; Hu Y; Guo L; Lin X; Tao S; Jin G; Sun J; Lu D; Zheng SL; Sun Y; Mo Z; Xu J
    Cancer Sci; 2011 Oct; 102(10):1916-20. PubMed ID: 21756274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.
    Zheng J; Liu F; Lin X; Wang X; Ding Q; Jiang H; Chen H; Lu D; Jin G; Hsing AW; Shao Q; Qi J; Ye Y; Wang Z; Gao X; Wang G; Chu LW; Ouyang J; Huang Y; Chen Y; Gao Y; Shi R; Wu Q; Wang M; Zhang Z; Hu Y; Sun J; Zheng SL; Gao X; Xu C; Mo Z; Sun Y; Xu J
    Prostate; 2012 Apr; 72(5):577-83. PubMed ID: 21796652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive prostate cancer phenotype and genome-wide association studies: where are we now?
    Pinto AR; Silva J; Pinto R; Medeiros R
    Pharmacogenomics; 2020 May; 21(7):487-503. PubMed ID: 32343194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between metformin medication, genetic variation and prostate cancer risk.
    Lee MJ; Jayalath VH; Xu W; Lu L; Freedland SJ; Fleshner NE; Kulkarni GS; Finelli A; van der Kwast TH; Hamilton RJ
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):96-105. PubMed ID: 32424261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of genome-wide and replication association studies on prostate cancer.
    Liu H; Wang B; Han C
    Prostate; 2011 Feb; 71(2):209-24. PubMed ID: 20690139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of common prostate cancer risk variants in an unscreened Romanian population.
    Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Guðmundsson J; Benónísdóttir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Manolescu A; Rafnar T; Halldórsson BV; Jinga V; Stefánsson K
    J Cell Mol Med; 2018 Mar; 22(3):1574-1582. PubMed ID: 29266682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.
    Lu L; Sun J; Isaacs SD; Wiley KE; Smith S; Pruett K; Zhu Y; Zhang Z; Wiklund F; Grönberg H; Walsh PC; Chang BL; Zheng SL; Isaacs WB; Xu J
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2132-6. PubMed ID: 19549809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
    Ishak MB; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.
    Grill S; Fallah M; Leach RJ; Thompson IM; Hemminki K; Ankerst DP
    J Clin Epidemiol; 2015 May; 68(5):563-73. PubMed ID: 25684153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.
    Ren S; Xu J; Zhou T; Jiang H; Chen H; Liu F; Na R; Zhang L; Wu Y; Sun J; Yang B; Gao X; Zheng SL; Xu C; Ding Q; Sun Y
    Prostate; 2013 Dec; 73(16):1824-35. PubMed ID: 24037738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.